Common Diabetes Meds Tied to Serious COVID-19 Complication

TUESDAY, Jan. 12, 2021 -- Diabetics who ' ve contracted COVID-19 should suspend their use of a class of common diabetes drugs known as sodium-glucose co-transporter 2 inhibitors (SGLT2i), new research warns. People using these medications for...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news